---
name: aria-pathway
description: >
  Regulatory submission pathway analysis and recommendation for FDA, EU MDR, and MFDS.
  Evaluates submission routes based on device classification and provides strategic pathway recommendations with timelines.
allowed-tools: Read Grep Glob ToolSearch
user-invocable: false
metadata:
  version: "0.0.4"
  category: "domain"
  status: "active"
  updated: "2026-02-11"
  modularized: "false"
  tags: "pathway, regulatory, FDA, EU-MDR, MFDS, submission, 510(k), PMA, CE-mark"
  knowledge-base-date: "2026-01"

# MoAI Extension: Progressive Disclosure
progressive_disclosure:
  enabled: true
  level1_tokens: 100
  level2_tokens: 2500

# MoAI Extension: Triggers
triggers:
  keywords: ["pathway", "submission route", "regulatory pathway", "510(k)", "PMA", "CE mark"]
  phases: ["run"]
---

# Regulatory Pathway Analysis Skill

## Quick Reference

**Purpose**: Identify regulatory submission pathways for FDA, EU MDR, and MFDS based on device classification.

**Input**: Device classification results (Class I/II/III for FDA, Class I/IIa/IIb/III for EU, Grade 1-4 for MFDS)
**Output**: Pathway recommendations, timeline ranges, key requirements, traffic light indicator
**Knowledge Base Date**: 2026-01

---

## Decision Framework

### FDA Pathways

#### Class I Devices
- **510(k) Exempt**: Devices listed in exempt categories (21 CFR 862-892)
  - Pathway: Registration only
  - Timeline: 1-2ê°œì›”
  - Requirements: Establishment registration, Device listing
  - Traffic Light: ğŸŸ¢ GREEN

- **510(k) Required**: Class I devices not in exempt categories
  - Pathway: 510(k) Premarket Notification
  - Timeline: 3-6ê°œì›” (standard) or 1-3ê°œì›” (expedited)
  - Requirements: Substantial equivalence to predicate device
  - Traffic Light: ğŸŸ¢ GREEN

#### Class II Devices
- **510(k) Premarket Notification** (most common)
  - Pathway: 510(k) submission with predicate device
  - Timeline: 3-6ê°œì›” (standard) or 1-3ê°œì›” (expedited)
  - Requirements: Predicate search, substantial equivalence demonstration, performance testing
  - Traffic Light: ğŸŸ¢ GREEN

- **De Novo Classification Request**
  - When: No valid predicate exists, low-moderate risk device
  - Timeline: 6-12ê°œì›”
  - Requirements: Special controls, risk mitigation documentation
  - Traffic Light: ğŸŸ¡ YELLOW (escalate to expert)

#### Class III Devices
- **PMA (Premarket Approval)**
  - Pathway: Full clinical study and PMA submission
  - Timeline: 12-18+ê°œì›”
  - Requirements: Clinical data, manufacturing quality system, risk analysis
  - Traffic Light: ğŸŸ¡ YELLOW (escalate to expert)

- **HDE (Humanitarian Device Exemption)**
  - When: Rare disease (<8,000 patients/year in US)
  - Timeline: 9-15ê°œì›”
  - Requirements: IRB approval, probable benefit demonstration
  - Traffic Light: ğŸŸ¡ YELLOW (escalate to expert)

---

### EU MDR Pathways

#### Class I Devices
- **Self-Declaration (Annex IV)**
  - When: Non-sterile, non-measuring function
  - Pathway: Technical documentation + DoC
  - Timeline: 2-4ê°œì›”
  - Requirements: Technical file, risk management, clinical evaluation
  - Notified Body: Not required
  - Traffic Light: ğŸŸ¢ GREEN

- **Notified Body Certification (Annex IV for sterile/measuring)**
  - When: Sterile or with measuring function
  - Pathway: Technical documentation + Notified Body review
  - Timeline: 4-6ê°œì›”
  - Requirements: Technical file, sterility validation (if sterile)
  - Traffic Light: ğŸŸ¢ GREEN

#### Class IIa Devices
- **Notified Body Certification (Annex IX or X)**
  - Pathway: QMS certification (Annex IX) or Type Examination (Annex X)
  - Timeline: 6-12ê°œì›”
  - Requirements: Technical documentation, Clinical Evaluation Report, Post-Market Surveillance Plan
  - Traffic Light: ğŸŸ¡ YELLOW (moderate complexity)

#### Class IIb Devices
- **Notified Body Certification (Annex IX or X)**
  - Pathway: Full QMS certification (Annex IX) or Type Examination + Product QMS (Annex X)
  - Timeline: 8-14ê°œì›”
  - Requirements: Technical documentation, Clinical Evaluation Report, PMCF plan
  - Traffic Light: ğŸŸ¡ YELLOW (moderate-high complexity)

#### Class III Devices
- **Notified Body Full QMS Certification (Annex IX)**
  - Pathway: Full QMS review + clinical investigation
  - Timeline: 12-18+ê°œì›”
  - Requirements: Clinical investigation data, comprehensive technical documentation
  - Traffic Light: ğŸŸ¡ YELLOW (escalate to expert)

---

### MFDS Pathways

#### Grade 1 (Class I equivalent)
- **ì œí’ˆ ì‹ ê³  (Product Registration)**
  - Pathway: Registration with MFDS
  - Timeline: 1-3ê°œì›”
  - Requirements: Product specifications, labeling, manufacturing documentation
  - Clinical Data: Not required
  - Traffic Light: ğŸŸ¢ GREEN

#### Grade 2 (Class II equivalent)
- **ì œí’ˆ í—ˆê°€ (Product Approval)**
  - Pathway: Pre-market approval submission
  - Timeline: 3-9ê°œì›”
  - Requirements: Non-clinical test data, risk analysis, labeling
  - Clinical Data: Non-clinical testing sufficient for most devices
  - Traffic Light: ğŸŸ¢ GREEN to ğŸŸ¡ YELLOW (depending on complexity)

#### Grade 3 (Class III equivalent)
- **ì œí’ˆ í—ˆê°€ (Product Approval with Clinical Data)**
  - Pathway: Pre-market approval with clinical/non-clinical data
  - Timeline: 9-15ê°œì›”
  - Requirements: Clinical or comprehensive non-clinical data, risk management
  - Traffic Light: ğŸŸ¡ YELLOW (escalate to expert)

#### Grade 4 (Highest risk)
- **ì œí’ˆ í—ˆê°€ with ì„ìƒì‹œí—˜ (Product Approval with Clinical Trial)**
  - Pathway: Clinical trial + pre-market approval
  - Timeline: 12-18+ê°œì›”
  - Requirements: IRB-approved clinical trial, comprehensive clinical data
  - Traffic Light: ğŸŸ¡ YELLOW (escalate to expert)

---

## Workflow

### Step 1: Load Classification Data

Use classification results from prior `/aria:classify` execution:
- Check for `.aria/products/<product-name>/<date>/classification.summary.md`
- Extract device classification for each target region
- If classification data NOT available:
  - Display warning: **"âš ï¸ ë¶„ë¥˜ ë°ì´í„°ê°€ ì—†ìŠµë‹ˆë‹¤. ë¨¼ì € `/aria:classify` ëª…ë ¹ì„ ì‹¤í–‰í•˜ì„¸ìš”."**
  - Traffic Light: ğŸŸ¡ YELLOW
  - STOP workflow

### Step 2: Select Pathways per Region

Based on loaded classification data:

**FDA Pathway Selection Logic**:
- Class I + Exempt â†’ Registration only (ğŸŸ¢ GREEN, 1-2ê°œì›”)
- Class I + Non-exempt â†’ 510(k) (ğŸŸ¢ GREEN, 3-6ê°œì›”)
- Class II + Valid predicate â†’ 510(k) (ğŸŸ¢ GREEN, 3-6ê°œì›”)
- Class II + No predicate â†’ De Novo (ğŸŸ¡ YELLOW, 6-12ê°œì›”)
- Class III â†’ PMA (ğŸŸ¡ YELLOW, 12-18+ê°œì›”)

**EU MDR Pathway Selection Logic**:
- Class I (non-sterile, non-measuring) â†’ Self-declaration (ğŸŸ¢ GREEN, 2-4ê°œì›”)
- Class I (sterile or measuring) â†’ Notified Body Annex IV (ğŸŸ¢ GREEN, 4-6ê°œì›”)
- Class IIa â†’ Notified Body Annex IX/X (ğŸŸ¡ YELLOW, 6-12ê°œì›”)
- Class IIb â†’ Notified Body Annex IX/X (ğŸŸ¡ YELLOW, 8-14ê°œì›”)
- Class III â†’ Notified Body Annex IX + Clinical Investigation (ğŸŸ¡ YELLOW, 12-18+ê°œì›”)

**MFDS Pathway Selection Logic**:
- Grade 1 â†’ ì‹ ê³  (ğŸŸ¢ GREEN, 1-3ê°œì›”)
- Grade 2 â†’ í—ˆê°€ (ğŸŸ¢-ğŸŸ¡, 3-9ê°œì›”)
- Grade 3 â†’ í—ˆê°€ with clinical data (ğŸŸ¡ YELLOW, 9-15ê°œì›”)
- Grade 4 â†’ í—ˆê°€ with clinical trial (ğŸŸ¡ YELLOW, 12-18+ê°œì›”)

### Step 3: Multi-Region Comparison

When multiple target regions selected:
- Generate comparison table: Region | Pathway | Timeline | Key Requirements
- Identify critical path (longest timeline)
- Highlight common dependencies (e.g., shared testing data)
- Recommend parallel vs. sequential submission strategy

### Step 4: Assign Overall Traffic Light

- **ğŸŸ¢ GREEN**: All pathways are low-risk (Class I/IIa, Grade 1-2, no clinical trials)
- **ğŸŸ¡ YELLOW**: Any pathway requires Notified Body, clinical data, or De Novo/PMA

### Step 5: Generate Output

Output structure (Korean language):

```markdown
# ê·œì œ ê²½ë¡œ ë¶„ì„ ê²°ê³¼

## ì œí’ˆ ì •ë³´
- ì œí’ˆëª…: [Product Name]
- ë¶„ì„ ì¼ì: [YYYY-MM-DD]

## ê²½ë¡œ ê¶Œì¥ì‚¬í•­

### FDA (ë¯¸êµ­)
- **ê²½ë¡œ**: [Pathway Name in Korean]
- **ì˜ˆìƒ ì†Œìš” ê¸°ê°„**: [Timeline Range]
- **ì£¼ìš” ìš”êµ¬ì‚¬í•­**:
  - [Requirement 1]
  - [Requirement 2]
- **ë°ì´í„° ì¶œì²˜**: FDA 510(k) Guidance / FDA PMA Guidance

### EU MDR (ìœ ëŸ½)
- **ê²½ë¡œ**: [Pathway Name in Korean]
- **ì˜ˆìƒ ì†Œìš” ê¸°ê°„**: [Timeline Range]
- **ì¸ì¦ ê¸°ê´€ í•„ìš” ì—¬ë¶€**: [Yes/No]
- **ì£¼ìš” ìš”êµ¬ì‚¬í•­**:
  - [Requirement 1]
  - [Requirement 2]
- **ë°ì´í„° ì¶œì²˜**: EU MDR Annex IV/IX/X

### MFDS (í•œêµ­)
- **ê²½ë¡œ**: [Pathway Name in Korean]
- **ì˜ˆìƒ ì†Œìš” ê¸°ê°„**: [Timeline Range]
- **ì£¼ìš” ìš”êµ¬ì‚¬í•­**:
  - [Requirement 1]
  - [Requirement 2]
- **ë°ì´í„° ì¶œì²˜**: ì˜ë£Œê¸°ê¸°ë²• ì‹œí–‰ê·œì¹™

## ë‹¤ì¤‘ ì‹œì¥ ë¹„êµí‘œ

| ì§€ì—­ | ê²½ë¡œ | ì†Œìš” ê¸°ê°„ | ì£¼ìš” ìš”êµ¬ì‚¬í•­ |
|------|------|-----------|---------------|
| FDA  | [...] | [...ê°œì›”] | [...]         |
| EU MDR | [...] | [...ê°œì›”] | [...]       |
| MFDS | [...] | [...ê°œì›”] | [...]        |

**ìµœì¥ ê²½ë¡œ (Critical Path)**: [Region with longest timeline]

## ìœ„í—˜ë„ í‰ê°€
- **Traffic Light**: [ğŸŸ¢ GREEN / ğŸŸ¡ YELLOW]
- **í‰ê°€**: [Risk assessment in Korean]

[If YELLOW]: **âš ï¸ ì „ë¬¸ê°€ ê²€í†  ê¶Œì¥**: í•´ë‹¹ ê²½ë¡œëŠ” ë³µì¡ë„ê°€ ë†’ìœ¼ë¯€ë¡œ ê·œì œ ì „ë¬¸ê°€ì™€ ìƒë‹´í•˜ì‹œê¸° ë°”ëë‹ˆë‹¤.

## ë‹¤ìŒ ë‹¨ê³„ ì œì•ˆ
1. `/aria:estimate` ëª…ë ¹ìœ¼ë¡œ ë¹„ìš© ë° ì¼ì • ì¶”ì •
2. ê·œì œ ì „ë¬¸ê°€ì™€ ê²½ë¡œ ì„ íƒ ê²€í† 
3. ê° ì‹œì¥ë³„ ì¤€ë¹„ ë¬¸ì„œ ëª©ë¡ í™•ì¸

## ë©´ì±… ì¡°í•­
âš ï¸ **ë³¸ ìë£ŒëŠ” ì°¸ê³  ì •ë³´ì´ë©°, ê·œì œ ìë¬¸ì´ ì•„ë‹™ë‹ˆë‹¤.** ì‹¤ì œ ê·œì œ ê²½ë¡œëŠ” ì œí’ˆ íŠ¹ì„±, ì‹œì¥ ìƒí™©, ê·œì œ ê¸°ê´€ ìš”êµ¬ì‚¬í•­ì— ë”°ë¼ ë‹¬ë¼ì§ˆ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ìµœì¢… ê²°ì • ì „ ê·œì œ ì „ë¬¸ê°€ì™€ ìƒë‹´í•˜ì‹œê¸° ë°”ëë‹ˆë‹¤.

---
**ìƒì„± ì¼ì‹œ**: [Timestamp]
```

### Step 6: Generate Context Simplifier Summary

Create `.summary.md` file for downstream pipeline:

```markdown
# Pathway Summary

**Product**: [Product Name]
**Date**: [YYYY-MM-DD]

## Selected Pathways
- **FDA**: [Pathway] ([Timeline])
- **EU MDR**: [Pathway] ([Timeline])
- **MFDS**: [Pathway] ([Timeline])

## Critical Path
- **Region**: [Region with longest timeline]
- **Duration**: [Timeline]

## Traffic Light
- **Overall Risk**: [GREEN/YELLOW]

---
This summary is consumed by `/aria:estimate` and `/aria:plan` commands.
```

---

## Data Source Strategy

1. **Built-in Knowledge** (Primary): Embedded pathway frameworks from FDA, EU MDR, MFDS regulations
2. **Loaded Classification Data** (Input): `.summary.md` from `/aria:classify`
3. **Notion MCP** (Supplementary): Organization-specific pathway precedents and timeline data
4. **Context7 MCP** (Verification): External regulatory pathway document verification

For MCP integration patterns (tool discovery, graceful degradation, source attribution), see `skills/connectors/SKILL.md`.

---

## Output Template (Korean)

See Step 5 for complete output structure. All user-facing text MUST be in Korean except:
- Regulation codes (FDA 510(k), EU MDR Annex IX, etc.)
- Technical abbreviations (PMA, CE, QMS, etc.)

---

## Traffic Light Definitions

- **ğŸŸ¢ GREEN**: Low-risk pathways (Class I/IIa, Grade 1-2, no clinical trials, no Notified Body for complex reviews)
- **ğŸŸ¡ YELLOW**: Moderate-high risk (Class IIb/III, Grade 3-4, De Novo, PMA, clinical trials required, Notified Body for Class IIb/III)
- **ğŸ”´ RED**: Not used in pathway skill (all valid classifications have a pathway)

---

## Escalation Scenarios

Escalate to regulatory expert when:
- FDA Class III device (PMA pathway)
- EU MDR Class III device (clinical investigation required)
- MFDS Grade 4 device (clinical trial required)
- De Novo pathway (no predicate device)
- Multi-region submission with conflicting timelines

---

## VALID Framework Compliance

- **Verified**: All pathway selections cite regulation sources (FDA Guidance, EU MDR Annex, MFDS regulations)
- **Accurate**: Timeline ranges match published regulatory data (2026-01)
- **Linked**: References to specific FDA/EU/MFDS regulation sections included
- **Inspectable**: Decision logic transparent (classification â†’ pathway mapping clearly defined)
- **Deliverable**: Output stored in `.aria/products/<product-name>/<date>/pathway.md`

---

## Version History

**v1.0.0** (2026-02-11):
- Initial implementation for Phase 3
- FDA, EU MDR, MFDS pathway selection
- Multi-region comparison table
- Context Simplifier integration
- Korean language output
- Traffic light system
- VALID framework compliance

---

**Knowledge Base Cutoff**: 2026-01
**Next Update**: Quarterly regulatory updates
